NewslettersImmune Regulation NewsAlvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®By lbeveridge - July 8, 20220130Alvotech announced the initiation of the company’s confirmatory clinical study for AVT06, a biosimilar candidate to Eylea®.[Alvotech]Press Release